期刊文献+

高血压大鼠肝脏组织及外周血白细胞端粒长度及其相关性 被引量:2

Telomere lengths of liver tissues and peripheral blood leukocytes in hypertensive rats and their correlation
下载PDF
导出
摘要 目的探讨高血压大鼠外周血白细胞和肝脏组织端粒相对长度及二者相关性。方法将16只SD雄性大鼠随机分为高血压组和对照组各8只。高血压组采用双侧肾动脉后支结扎以及结扎后喂食8%NaCl饲料的方法构建高血压大鼠模型,对照组用标准饲料进行喂养。饲养4个月后比较两组大鼠肝脏组织及外周血白细胞端粒长度,并分析高血压大鼠外周血白细胞端粒与肝脏组织端粒的关系。结果高血压组大鼠肝脏组织及外周血白细胞端粒长度均短于对照组(均P<0.05),高血压组大鼠外周血白细胞与肝脏组织端粒长度呈正相关(P<0.05)。结论高血压大鼠外周血白细胞及肝脏组织端粒长度明显缩短,两者存在一定相关性。 Objective To investigate the relative telomere lengths of peripheral blood leukocytes and liver tissues in hypertensive rats and their correlation. Methods Sixteen male SD rats were randomly divided into hypertension group and control group,with 8 rats in each group. The hypertension group was given 8% Na Cl diet after bilateral posterior renal artery ligation to develop the hypertensive rat model,and the control group was given the normal diet. After four months of feeding,the telomere lengths of liver tissues and peripheral blood leukocytes of rats were compared between the two groups,and the relationship between peripheral blood leukocyte and liver tissue telomere lengths was analyzed. Results The telomere lengths of liver tissues and peripheral blood leukocytes of the rats in the hypertension group were shorter than those in the control group(all P〈0. 05),and there was a positive correlation between peripheral blood leukocyte and liver tissue telomere lengths of the rats in the hypertension group(P〈0. 05). Conclusion The telomere lengths of peripheral blood leukocytes and liver tissues decrease significantly in the hypertensive rats,and they show a certain correlation.
出处 《广西医学》 CAS 2018年第2期171-173,共3页 Guangxi Medical Journal
基金 国家自然科学基金(11672332) 天津市卫生局科技基金(2015KZ126) 天津市卫生计生委中医中西医结合科研课题(2015155) 天津市重点科研平台开放基金(WYKFZ201602) 武警后勤学院附属医院种子基金(FYM201517 FYQ201560)
关键词 高血压 端粒长度 大鼠 外周血白细胞 肝脏组织 Hypertension, Telomere length, Rat, Peripheral blood leukocyte, Liver tissue
  • 相关文献

参考文献7

二级参考文献73

  • 1Norberto C Chavez-Tapia,Tonatiuh Barrientos-Gutierrez,Felix I Tellez-ávila,Francisco Sánchez-ávila,Maria Antonieta Montao-Reyes,Misael Uribe.Insulin sensitizers in treatment of nonalcoholic fatty liver disease:Systematic review[J].World Journal of Gastroenterology,2006,12(48):7826-7831. 被引量:11
  • 2Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol, 2002,17 Suppl : S186-190.
  • 3Angulo P. Obesity and nonalcoholic fatty liver disease. Nutr Rev, 2007,65(6 Pt 2) :S57-63.
  • 4Machado M, Cortez-Pinto H. Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care, 2006,9 : 637-642.
  • 5Scott M, Grundy J. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab, 2007, 92: 399-404.
  • 6Fruchart JC, Nierman MC, Stroes ES, et al. New risk factors for atherosclerosis and patient risk assessment. Circulation,2004,109[suppl Ⅲ]: 15-19.
  • 7Targher G, Arcaro G. Non alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis, 2007, 191 : 235-240.
  • 8Schindhelm RK, Diamant M, Jacqueline M, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev, 2006, 22 : 437-443.
  • 9Targher G. Non-alcoholic fatty liver disease,the metabolic syndrome and the risk of cardiovascular disease:the plot thickens. Diabet Med,2007,24: 1-6.
  • 10Targher G,Bertolini L, Padovani R, et al. Increased prevalence of cardiovascular disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med, 2006,23:403-409.

共引文献41

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部